Dr Reddy's launches Parkinson's drug in US

Dr. Reddy's has obtained the approval of the United States Food and Drug Administration ( USFDA) for its abbreviated new drug application for Ropinirole Hydrochloride XR tablets to launch generic product.Ropinirole Hydrochloride XR tablets are bioequivalent generic version of Requip XL tablets, a registered trademark of pharma giant SmithKline Beecham.
Requip XL had reported sales of around $58 million for the 12 months period ended March 2012 in the US market according to IMS Health.
Dr Reddy's said its Ropinirole Hydrochloride XR tablets in 2 mg, 4 mg and 6 mg will be available in 30 and 90 count bottle sizes, 8 mg and 12 mg in 30 count bottle sizes.
http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/dr-reddys-launches-parkinsons-drug-in-us/articleshow/13894089.cms